Institution
Metro South Health
Recent research
- Health & MedicineOpen access
Background Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but neutropenia concerns continue to limit its use. Large real-world evidence on temporal risk patterns, re-initiation, and patient-level determinants remains limited. Methods We condu...
- Health & Medicine
OBJECTIVE: This study aimed to describe pathway timing and 90-day outcomes for long-stay inpatients discharged to residential aged care homes (RACHs), predominantly new entrants, and to explore potentially modifiable factors associated with delays and the composite unsuccessful p...
- Health & Medicine
BACKGROUND: A significant contributor to preventable medication related harm is opioids. Within Australian hospitals, opioids have contributed to deaths, hospital admissions, and in-hospital related harm. Given these harms, there is a need to ensure opioids are used safely and th...
- Health & MedicineOpen access
Frailty is associated with negative outcomes and adverse events in hospitals; however, limited formal education on frailty exists in this setting. Healthcare professionals across disciplines have expressed a need and want for frailty education and training. This study aimed to ex...
- Society & EconomicsOpen access
Hospital in the Home (HITH) can deliver acute-level care at home with comparable or improved outcomes and higher satisfaction than inpatient care. For Aboriginal and Torres Strait Islander peoples, Indigenous-led HITH models may offer particular benefits by combining quality care...
- Health & MedicineOpen access
Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy
Optimal dosing of vancomycin in critically ill patients receiving renal replacement therapy (RRT) is uncertain due to high pharmacokinetic variability. We aimed to develop individualised vancomycin dosing recommendations that optimise efficacy while minimising toxicity. Prospecti...
- Health & MedicineOpen access
Recurrent/Metastatic (R/M) ACC is aggressive with few effective treatment options. The role of surgery after chemotherapy remains unclear. Moreover, prognostic factors in R/M ACC are not well defined. R/M ACC patients treated at Princess Margaret Cancer Centre (2002–2019) were re...